| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Lennon David James serves as a Chief Executive Officer at WHWK. Across recent SEC filings that breaks down to 0 buys and 8 sells. Those positions are worth an estimated $2.2M at current prices.
Historically, Lennon David James's trades have earned a below-average insider score of 36/100 across 8 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -23.2%.
The biggest single holding is WHWK (~$2.2M) as Chief Executive Officer. The recent filings there lean toward selling, a net 322,264 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 9, 2026 | WHWK Whitehawk Therapeutics, Inc. | Chief Executive Officer | Sell | 14,500 | $3.38 | $49,010.00 | -2.7% | +8.7% | - | |
| Apr 8, 2026 | WHWK Whitehawk Therapeutics, Inc. | Chief Executive Officer | Sell | 260,427 | $3.45 | $899,537.86 | -32.8% | +21.7% | - | |
| Apr 2, 2026 | WHWK Whitehawk Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 26,858 | $3.48 | $93,465.84 | -3.3% | +22.5% | - | |
| Mar 2, 2026 | WHWK Whitehawk Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 5,100 | $3.31 | $16,878.96 | -10.3% | +37.3% | - | |
| Mar 3, 2025 | WHWK Whitehawk Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 5,690 | $2.35 | $13,371.50 | -14.5% | -24.3% | +44.3% | |
| Oct 3, 2024 | WHWK Whitehawk Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 9,689 | $1.94 | $18,796.66 | -29.8% | +63.5% | +2.1% |